Search Results - "Wertel, I"

LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death by A, Zając, J, Sumorek-Wiadro, A, Maciejczyk, E, Langner, I, Wertel, W, Rzeski, J, Jakubowicz-Gil

“…Gliomas are aggressive brain tumors with very high resistance to chemotherapy throughout the overexpression of multiple intracellular survival pathways…”
Get full text

Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment by Pawłowska, A., Suszczyk, D., Okła, K., Barczyński, B., Kotarski, J., Wertel, I.

“…Summary Immunotherapies based on anti‐programmed death 1/programmed death ligand 1 (PD‐1/PD‐L1) pathway inhibitors may turn out effective in ovarian cancer…”
Get full text

Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells by Surówka, J., Wertel, I., Okła, K., Bednarek, W., Tarkowski, R., Kotarski, J.

“…PURPOSE The aim of this study was to evaluate the influence of ovarian cancer cell lysates isolated from type I or type II ovarian cancer (OC) on the phenotype…”
Get full text

Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients by Wertel, I., Surówka, J., Polak, G., Barczyński, B., Bednarek, W., Jakubowicz-Gil, J., Bojarska-Junak, A., Kotarski, J.

“…The study was undertaken to evaluate macrophage-derived chemokine (CCL22) levels in the peritoneal fluid (PF) and plasma of patients with ovarian cancer ( n  =…”
Get full text

1095 The Evaluation of Natural Killer Cells in Ovarian Cancer Patients by Nowicka, A, Rogala, E, Wertel, I, Piekarczyk, W, Kotarski, J

Get full text

1091 Intracellular Expression of Interleukin-10 (IL-10) in Patients With Ovarian Cancer by Rogala, E, Nowicka, A, Wertel, I, Piekarczyk, W, Zakrzewski, M, Kotarski, J

Get full text

1103 Relationship Between IL-10 and Dendritic Cells in Ovarian Cancer Microenvironment by Wertel, I, Rogala, E, Nowicka, A, Jakubowicz-Gil, J, Polak, G, Tarkowski, R, Kotarski, J

Get full text

Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer by Wertel, I., Polak, G., Bednarek, W., Barczyński, B., Roliński, J., Kotarski, J.

“…Background: Evaluation of immature myeloid and lymphoid dendritic cells (DCs) in the peritoneal fluid (PF) and peripheral blood (PB) mononuclears of women with…”
Get full text

P766 The assessment of dendritic cells in endometriotic implants by Tarkowski, R., Polak, G., Wertel, I., Kotarski, J.

Get full text

Phenotype of Dendritic Cells Generated from Peripheral Blood Monocytes of Patients with Ovarian Cancer by Wertel, I, Bednarek, W, Stachowicz, N, Rogala, E, Nowicka, A, Kotarski, J

“…Abstract Objectives The aim of our study was to generate dendritic cells (DCs) from peripheral blood monocytes (PBMC) of patients suffering from ovarian…”
Get full text

P761 4-Hydroxy-2-nonenal expression in endometrial cysts by Polak, G., Tarkowski, R., Barczynski, B., Wertel, I., Kotarski, J.

Get full text

Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients by Pawłowska, Anna, Suszczyk, Dorota, Tarkowski, Rafał, Paduch, Roman, Kotarski, Jan, Wertel, Iwona

“…Ovarian cancer (OC) is one of the most lethal gynecological malignancies. Recent studies suggest a crucial role of the PD-1/PD-L1 pathway in OC pathogenesis…”
Get full text

PERITONEAL FLUID LACTOFERRIN LEVELS IN ENDOMETRIOTIC PATIENTS by Wertel, I, Tarkowski, R, Kotarski, J

Get full text

The role of dendritic ceils in cytotoxic immune response regulation in ovarian cancer micro-environment by Wertel, I, Barczynski, B, Kotarski, J

“…Ovarian cancer is the most lethal gynecological malignancy. At the time of diagnosis most patients present with an advanced stage of the disease and require…”
Get full text

Evaluation of Myeloid and Lymphoid Dendritic Cells in Peritoneal Fluid in Women with Non-malignant Ovarian Tumors by Wertel, Iwona, Kotarski, Jan, Roliński, Jacek, Bojarska-Junak, Agnieszka, Gogacz, Marek

“…Problem: Identification of myeloid and lymphoid dendritic cells (DCs) in peritoneal fluid (PF) and peripheral blood (PB) of patients with ovarian pathology…”
Get full text